All episodes
SCOUT· 25%30m·2026-03-19·News Politics
SCOUT· 25%30m·2026-03-19·News PoliticsSemaglutide Goes Generic: Big Pharma’s Moat Breaks
The Morning Brief · 920
India's semaglutide moment has arrived. As Novo Nordisk's patent expires on March 20th, over fifty generic brands are poised to flood the market potentially slashing monthly costs from ₹10,000 to ₹3,500. But this is no ordinary generic wave. Semaglutide is a complex peptide, cold chains are unforgiving, and patient…
Buzzmeter · cross-platform
25%
SCOUT
Scout bees are checking it out — divided opinions, the swarm hasn't committed.
Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
Recent reviews
- No reviews yet — be the first.
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.